We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Biotech holds its own in Q2.
- Authors
Lawrence, Stacy
- Abstract
The article gives an overview of the financial situation of biotech companies in the second quarter. Biotech companies are turning increasingly to debt which, excluding public investment in private equities, represented 27% of total funds raised, up from 16% represented in the first quarter of this year. Funding from public offerings and partnership deals did hold up, but it remains to be seen if the initial public offering (IPO) window will stay open much longer. The average amount raised in a biotech IPO fell precipitously in the last quarter from $83 million to $45 million.
- Subjects
CORPORATE finance; BIOTECHNOLOGY industries; GOING public (Securities); FINANCE; INVESTMENTS; BUSINESS enterprises; BUSINESS partnerships
- Publication
Nature Biotechnology, 2004, Vol 22, Issue 8, p938
- ISSN
1087-0156
- Publication type
Article
- DOI
10.1038/nbt0804-938